Sanofi Downsizes Executive Board

00:07 EST 13 Feb 2020 | CHEManager

Paul Hudson, new CEO of Sanofi, has taken quick steps to implement a plan announced on Feb. 6 to reduce the company's executive committee from 14 to 10 members. At the company’s Q4 2019 results presentation, Hudson said he hoped to allocate more central expertise in the business units and increase accountability.

Original Article: Sanofi Downsizes Executive Board


More From BioPortfolio on "Sanofi Downsizes Executive Board"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...